ESC 2026: Statins show worth despite emergence of PCSK9 inhibitors

Data ReadoutpositiveStatinsPCSK9 inhibitorsPositive

AI Analysis

Summary

The STAREE trial, an Australia-based study presented at ESC 2026, demonstrates that statins provide preventative cardiovascular benefits in older patients, supporting their continued use despite emerging PCSK9 inhibitor therapies.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

STAREE trial demonstrated preventative effects of statins in older patients

Importance:6/10

Sentiment:

0.60

STAREE trialstatinscardiovascularpreventative therapyolder patientsESC 2026

Related Companies

$TRAX

Read the original article

Published by Pharmaceutical Technology on August 29, 2026 6:25 AM

Read Original